HUP9802132A3 - Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them - Google Patents
Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing themInfo
- Publication number
- HUP9802132A3 HUP9802132A3 HU9802132A HUP9802132A HUP9802132A3 HU P9802132 A3 HUP9802132 A3 HU P9802132A3 HU 9802132 A HU9802132 A HU 9802132A HU P9802132 A HUP9802132 A HU P9802132A HU P9802132 A3 HUP9802132 A3 HU P9802132A3
- Authority
- HU
- Hungary
- Prior art keywords
- cyanamides
- sulfonyl
- biphenyl
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- CBTRBYGUVACZIU-UHFFFAOYSA-N n-cyano-2-phenylbenzenesulfonamide Chemical class N#CNS(=O)(=O)C1=CC=CC=C1C1=CC=CC=C1 CBTRBYGUVACZIU-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/16—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19741635A DE19741635A1 (de) | 1997-09-22 | 1997-09-22 | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9802132D0 HU9802132D0 (en) | 1998-11-30 |
HUP9802132A2 HUP9802132A2 (hu) | 2000-02-28 |
HUP9802132A3 true HUP9802132A3 (en) | 2000-04-28 |
Family
ID=7843124
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9802132A HUP9802132A3 (en) | 1997-09-22 | 1998-09-22 | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them |
Country Status (19)
Country | Link |
---|---|
US (1) | US5968978A (hu) |
EP (1) | EP0903339B1 (hu) |
JP (1) | JP4272278B2 (hu) |
KR (1) | KR19990029983A (hu) |
CN (2) | CN1212255A (hu) |
AR (1) | AR015170A1 (hu) |
AT (1) | ATE210638T1 (hu) |
AU (1) | AU755553B2 (hu) |
BR (1) | BR9803968A (hu) |
CA (1) | CA2247749A1 (hu) |
CZ (1) | CZ300698A3 (hu) |
DE (2) | DE19741635A1 (hu) |
DK (1) | DK0903339T3 (hu) |
ES (1) | ES2169467T3 (hu) |
HK (1) | HK1040980A1 (hu) |
HU (1) | HUP9802132A3 (hu) |
PL (1) | PL328762A1 (hu) |
PT (1) | PT903339E (hu) |
TR (1) | TR199801871A3 (hu) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19737224A1 (de) * | 1997-08-27 | 1999-03-18 | Hoechst Marion Roussel De Gmbh | Pharmazeutisches Kombinationspräparat aus einem Inhibitor des Natrium-Wasserstoff-Austauschers und einem Arzneimittel zur Behandlung von Herz-Kreislauferkrankungen |
DE19804251A1 (de) | 1998-02-04 | 1999-08-05 | Hoechst Marion Roussel De Gmbh | Biphenylsulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
CA2318446C (en) * | 1998-03-04 | 2008-09-23 | Takeda Chemical Industries, Ltd. | Sustained-release preparation for aii antagonist, production and use thereof |
DE19820064A1 (de) * | 1998-05-06 | 1999-11-11 | Hoechst Marion Roussel De Gmbh | Substituierte Sulfonylcyanamide, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
IL140905A0 (en) * | 1998-07-20 | 2002-02-10 | Smithkline Beecham Corp | Bioenhanced formulations comprising eprosartan in oral solid dosage form |
DE10018401A1 (de) * | 2000-04-13 | 2001-10-25 | Boehringer Ingelheim Pharma | Verwendung von Bradycardica bei der Behandlung von mit Hypertrophie einhergehenden Myocarderkrankungen und neue Arzneimittelkombinationen |
ES2316618T3 (es) | 2001-10-25 | 2009-04-16 | Emory University | Cateter para perfusion modificada. |
WO2006069170A2 (en) * | 2004-12-22 | 2006-06-29 | Emory University | Therapeutic adjuncts to enhance the organ protective effects of postconditioning |
US20070160645A1 (en) * | 2001-10-25 | 2007-07-12 | Jakob Vinten-Johansen | PostConditioning System And Method For The Reduction Of Ischemic-Reperfusion Injury In The Heart And Other Organs |
DE10206354A1 (de) * | 2002-02-14 | 2003-08-28 | Aventis Pharma Gmbh | Verwendung von Inhibitoren des Natrium-abhängigen Chlorid-Bicarbonat-Austauschers zur Behandlung von thrombotischen und inflammatorischer Erkrankungen |
US20040138306A1 (en) * | 2002-07-25 | 2004-07-15 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Use of a specific cyclic amine derivative or the pharmaceutically acceptable salts thereof for the treatment or prevention of heart failure |
US20060099230A1 (en) * | 2004-11-10 | 2006-05-11 | Chin-Chih Chiang | Novel formulations of eprosartan with enhanced bioavailability |
EP1762179A1 (en) * | 2005-09-07 | 2007-03-14 | Boehringer Ingelheim Vetmedica Gmbh | Method for improving diagnostic quality in echocardiography |
US7541492B2 (en) * | 2005-10-26 | 2009-06-02 | Toyota Jidosha Kabushiki Kaisha | Perfluoroalkanesulfonamide compounds |
JP2014521713A (ja) | 2011-08-12 | 2014-08-28 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミット ベシュレンクテル ハフツング | 味をマスキングした医薬組成物 |
WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
CN113527152B (zh) * | 2021-08-09 | 2023-07-28 | 西北农林科技大学 | 一种联苯磺酰胺类化合物及其防治农作物害虫的方法 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2533126A1 (de) * | 1975-07-24 | 1977-02-10 | Bayer Ag | Polytriazine und ein verfahren zu deren herstellung |
DE2533127A1 (de) * | 1975-07-24 | 1977-02-10 | Bayer Ag | Polytriazine und ein verfahren zu deren herstellung |
CA2062558A1 (en) * | 1991-03-08 | 1992-09-09 | Prasun K. Chakravarty | Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists |
EP0503838A3 (en) * | 1991-03-08 | 1992-10-07 | Merck & Co. Inc. | Heterocyclic compounds bearing acidic functional groups as angiotensin ii antagonists |
CA2109524A1 (en) * | 1991-05-10 | 1992-11-11 | Prasun K. Chakravarty | Acidic aralkyl triazole derivatives active as angiotensin ii antagonists |
EP0855392A3 (de) * | 1997-01-22 | 2000-01-05 | Hoechst Aktiengesellschaft | Fünfgliedrige Heterocyclen mit Biphenylsulfonylsubstitution, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1997
- 1997-09-22 DE DE19741635A patent/DE19741635A1/de not_active Withdrawn
-
1998
- 1998-09-16 AT AT98117529T patent/ATE210638T1/de not_active IP Right Cessation
- 1998-09-16 DE DE59802412T patent/DE59802412D1/de not_active Expired - Lifetime
- 1998-09-16 DK DK98117529T patent/DK0903339T3/da active
- 1998-09-16 EP EP98117529A patent/EP0903339B1/de not_active Expired - Lifetime
- 1998-09-16 ES ES98117529T patent/ES2169467T3/es not_active Expired - Lifetime
- 1998-09-16 PT PT98117529T patent/PT903339E/pt unknown
- 1998-09-18 CZ CZ983006A patent/CZ300698A3/cs unknown
- 1998-09-18 AR ARP980104685A patent/AR015170A1/es unknown
- 1998-09-21 JP JP26685098A patent/JP4272278B2/ja not_active Expired - Fee Related
- 1998-09-21 US US09/157,589 patent/US5968978A/en not_active Expired - Lifetime
- 1998-09-21 CA CA002247749A patent/CA2247749A1/en not_active Abandoned
- 1998-09-21 BR BR9803968-7A patent/BR9803968A/pt not_active IP Right Cessation
- 1998-09-21 KR KR1019980038932A patent/KR19990029983A/ko not_active Application Discontinuation
- 1998-09-21 TR TR1998/01871A patent/TR199801871A3/tr unknown
- 1998-09-21 AU AU86108/98A patent/AU755553B2/en not_active Ceased
- 1998-09-22 HU HU9802132A patent/HUP9802132A3/hu unknown
- 1998-09-22 PL PL98328762A patent/PL328762A1/xx unknown
- 1998-09-22 CN CN98119536A patent/CN1212255A/zh active Pending
-
2000
- 2000-02-25 CN CN00102661A patent/CN1326928A/zh active Pending
-
2002
- 2002-04-03 HK HK02102461.4A patent/HK1040980A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
US5968978A (en) | 1999-10-19 |
PT903339E (pt) | 2002-06-28 |
JPH11189581A (ja) | 1999-07-13 |
AU755553B2 (en) | 2002-12-12 |
TR199801871A2 (xx) | 1999-04-21 |
ES2169467T3 (es) | 2002-07-01 |
HUP9802132A2 (hu) | 2000-02-28 |
CN1326928A (zh) | 2001-12-19 |
PL328762A1 (en) | 1999-03-29 |
DE19741635A1 (de) | 1999-03-25 |
EP0903339A2 (de) | 1999-03-24 |
KR19990029983A (ko) | 1999-04-26 |
CA2247749A1 (en) | 1999-03-22 |
CZ300698A3 (cs) | 1999-04-14 |
HK1040980A1 (zh) | 2002-06-28 |
BR9803968A (pt) | 2000-05-02 |
ATE210638T1 (de) | 2001-12-15 |
JP4272278B2 (ja) | 2009-06-03 |
EP0903339A3 (de) | 1999-03-31 |
AU8610898A (en) | 1999-04-01 |
HU9802132D0 (en) | 1998-11-30 |
CN1212255A (zh) | 1999-03-31 |
TR199801871A3 (tr) | 1999-04-21 |
DE59802412D1 (de) | 2002-01-24 |
EP0903339B1 (de) | 2001-12-12 |
AR015170A1 (es) | 2001-04-18 |
DK0903339T3 (da) | 2002-04-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0103884A3 (en) | Arylsulfonanilide urea-derivatives, pharmaceutical compositions containing them and their use | |
HU0500549D0 (en) | Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof | |
HUP9800792A3 (en) | Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same | |
IL123648A0 (en) | 1,4-Benzothiazepine-1,1-dioxides their preparation and pharmaceutical compositions containing them | |
IL135646A0 (en) | α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME | |
HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
HUP0001309A3 (en) | 1-phenyl-4-benzylpiperazines and pharmaceutical compositions containing them | |
IL131319A0 (en) | 3-Piperidyl-4- oxoquinazoline derivatives and medicinal compositions containing the same | |
GB9706089D0 (en) | Pharmaceutical composition | |
HUP9904694A3 (en) | Spiropyrrolidine derivatives, their use and pharmaceutical compositions containing them | |
HUP0000762A3 (en) | 2-amino-6-(2-substituted-4-phenoxy)-substituted-pyridines, and pharmaceutical compositions containing them | |
HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
HUP0002272A3 (en) | Aroyl-piperazine derivatives, their preparation pharmaceutical compositions containing them and their use | |
HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
HUP9802132A3 (en) | Biphenyl-sulfonyl-cyanamides, their use and pharmaceutical compositions containing them | |
HUP0105075A3 (en) | 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives, their use and pharmaceutical compositions containing them | |
HUP0004561A3 (en) | Dihydrobenzofurans, pharmaceutical compositions containing them and use thereof | |
HUP0100085A3 (en) | Biphenylamidine derivatives and pharmaceutical compositions containing them | |
HUP0101701A3 (en) | Substituted betha-alanines and pharmaceutical compositions comprising them | |
HUP0001940A3 (en) | Benzisothiazole derivatives, their use and pharmaceutical compositions containing them | |
IL133928A0 (en) | Pharmaceutical composition containing peptichemio | |
HUP0104834A3 (en) | Sulphonyloxazolamines, their use, pharmaceutical compositions containing them and their preparation | |
HUP0101733A3 (en) | Pharmaceutical compositions containing sulfonyl-dipeptides and their use | |
IL136045A0 (en) | Pyridylpyrrole derivatives and pharmaceutical compositions containing the same | |
HUP9802590A3 (en) | Indan-, benzothiophene-, benzofuran- and indolesulfonamide derivatives, their use and pharmaceutical compositions containing them |